Treatment of magnesium deficiency after liver transplantation: randomized controlled clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002430

Enrollment

Unknown

Registered

2012-08-19

Start date

2012-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transplant recipient, magnesium deficiency

Interventions

Magnesium group:Magnesium

Calcitriol group:Calcitriol

Mg-D joint group:Magnesium, Calcitriol

control group:no

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Liver transplant recipient; 2. Aged 20-70 years; 3. Magnesium deficiency; 4. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Other organ transplantation; 3. Patients who use drug magnesium or active vitamin D 1 months before the beginning of the study; 4. Patients with delirium or dementia, who cannot obtain informed consent; 5. Not suitable for clinical trials because of other reasons.

Design outcomes

Primary

Measure	Time frame
Serum magnesium;	—

Secondary

Measure	Time frame
Vitamin D levels;Calcineurin inhibitors levels;Blood glucose;Insulin in serum;Electrolytes;Renal function;Liver function;	—

Contacts

Public ContactShen Zhongyang

niuyujian@yahoo.com.cn+86 10 57976840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026